Literature DB >> 21511235

Clinical and molecular characteristics of Pendred syndrome.

P Kopp1, A Bizhanova.   

Abstract

Pendred syndrome is an autosomal recessive disorder defined by sensorineural deafness, goiter and a partial defect in the organification of iodide. It is caused by biallelic mutations in the SLC26A4 gene, which encodes pendrin, a multifunctional anion exchanger. At the level of the inner ear, pendrin is important for the creation of a normal endolymph composition and the maintenance of the endocochlear potential. In the thyroid, pendrin is expressed at the apical membrane of thyroid follicular cells and it appears to be involved in mediating iodide efflux into the lumen and/or maintenance of the follicular pH. Goiter development and hypothyroidism vary among affected individuals and seem to be partially dependent on nutritional iodide intake. In the kidney, pendrin functions as a chloride/bicarbonate exchanger. Elucidation of the molecular basis of Pendred syndrome and the function of pendrin has provided unexpected novel insights into the pathophysiology of the inner ear, thyroid hormone synthesis, and chloride/bicarbonate exchange in the kidney.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511235     DOI: 10.1016/j.ando.2011.03.010

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  10 in total

Review 1.  Congenital hypothyroidism and the importance of universal newborn screening.

Authors:  Firas A Salim; Surendra K Varma
Journal:  Indian J Pediatr       Date:  2013-12-11       Impact factor: 1.967

Review 2.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

3.  Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function.

Authors:  Silvia Dossena; Aigerim Bizhanova; Charity Nofziger; Emanuele Bernardinelli; Josef Ramsauer; Peter Kopp; Markus Paulmichl
Journal:  Cell Physiol Biochem       Date:  2011-11-18

4.  The effect of GJB2 and SLC26A4 gene mutations on rehabilitative outcomes in pediatric cochlear implant patients.

Authors:  Yu-jun Yan; Yun Li; Tao Yang; Qi Huang; Hao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-08       Impact factor: 2.503

5.  Outcomes of Cochlear Implantation in Patients with Pendred syndrome: A Systematic Review and Narrative Synthesis.

Authors:  Kirsty Biggs; Amy Lovett; Chris Metcalfe; Jameel Muzaffar; Peter Monksfield; Manohar Bance
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

6.  SLC26A4 mutation in Pendred syndrome with hypokalemia: A case report.

Authors:  Ya-Ting Lu; Lin Wang; Le-Le Hou; Ping-Ping Zheng; Qian Xu; Da-Tong Deng
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

7.  Iodide transport: implications for health and disease.

Authors:  Liuska Pesce; Peter Kopp
Journal:  Int J Pediatr Endocrinol       Date:  2014-05-30

Review 8.  Novel Roles for Chloride Channels, Exchangers, and Regulators in Chronic Inflammatory Airway Diseases.

Authors:  Monica Sala-Rabanal; Zeynep Yurtsever; Kayla N Berry; Tom J Brett
Journal:  Mediators Inflamm       Date:  2015-11-03       Impact factor: 4.711

9.  A comparison of thyroidal protection by stable iodine or perchlorate in the case of acute or prolonged radioiodine exposure.

Authors:  Stefan Eder; Cornelius Hermann; Andreas Lamkowski; Manabu Kinoshita; Tetsuo Yamamoto; Michael Abend; Nariyoshi Shinomiya; Matthias Port; Alexis Rump
Journal:  Arch Toxicol       Date:  2020-07-12       Impact factor: 5.153

10.  Association between Ménière's disease and thyroid diseases: a nested case-control study.

Authors:  So Young Kim; Young Shin Song; Jee Hye Wee; Chanyang Min; Dae Myoung Yoo; Hyo Geun Choi
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.